Contrast-induced nephropathy (CIN) is an iatrogenic medical event for which there is not yet
a successful therapy. Increasing evidence in rodents has suggested that this disease is …

Contrast is widely used in invasive image examinations such as computed tomography (CT)
and angiography; however, the risk of contrast-induced nephropathy (CIN) is high. The aim …

Oxidative stress appears to possess a central role in CIN pathophysiology. Resveratrol
(Res) and lycopene (Lyc) are strong natural antioxidants evaluated in a limited number of …

Aim: Contrast-induced nephropathy (CIN) is a common cause of hospital-acquired acute
renal failure. Although it is so common, there has been no approved therapy yet. We aimed …

PURPOSE Contrast agents administered in diagnostic imaging or interventional procedures
of clinical radiology may cause contrast-induced nephropathy (CIN). Preventive measures …

Objectives Currently, the use of iodinated contrast media in diagnostic imaging has been
increased in clinical medicine. Contrast‐induced nephropathy (CIN) is an important adverse …

OBJECTIVE: To date, there is no effective treatment of contrast medium (CM)-induced
nephropathy. Multiple studies documented a protective role of hydration and N-acetylcystein …

Contrast-induced nephropathy (CIN) is an iatrogenic medical event in stable cardiology
patients that may lead to acute renal failure. There is no current successful therapy to …

Currently, the number of imaging and interventional procedures that use contrast agents
(CAs) is gradually increasing. Contrast-induced nephropathy (CIN) is the most important CA …

Contrast-induced nephropathy (CIN) is a leading cause of hospital-acquired acute kidney
injury as a result of iodinated contrast-media use for diagnostic purposes. Pathophysiology …